A 33-year-old Bengaluru woman has delivered a healthy baby girl, with the assistance of timely medical intervention after ...

BrightHeart’s AI-based CHD detection platform received FDA clearance in 2024 and is currently being used at a limited range ...

GeneDx announced GenomeDx Prenatal™, a whole genome sequencing test that delivers fast, comprehensive insights when fetal ...

AI assistance reduced interpretation time by 48 seconds per examination while increasing clinician confidence scores.

This doctor brings care to the middle of nowhere—via private jet. For rural Americans, he's a rare lifeline to specialty care ...

BrightHeart delivers expert-level ultrasound screening for complex organs, helping OB-GYNs improve the detection of ...

GeneDx , a leader in delivering improved health outcomes through genomic insights, today announced GenomeDx Prenataltm, whole genome sequencing (WGS) designed to deliver clear, reliable answers during ...

An MRI confirmed a complete abdominal ectopic pregnancy and that Lopez's uterus was empty. The baby was sitting in the ...

BrightHeart, a global leader in artificial intelligence (AI) solutions for prenatal ultrasound, today announced the closing of an €11 million Series A financing round. The round was co-led by Odyssée ...

Genedx Holding Corp. launched Genomedx Prenatal, its whole genome sequencing test, to provide more definitive diagnoses of the causes of fetal abnormalities identified by ultrasound. By combining the ...

BrightHeart, a global leader in artificial intelligence (AI) solutions for prenatal ultrasound, today announced the closing ...

BrightHeart, a global leader in artificial intelligence (AI) solutions for prenatal ultrasound, today announced the closing of an ?11 million Series A financing round. The round was co-led by Odyssée ...